Plasmonically Reinforced Self‐Sufficient Nanozymes Dysregulating Redox Homeostasis for Augmented Cascade Catalytic Oncotherapy
Advanced Healthcare Materials · 2026-08 · 15 (29)
DOI: 10.1002/adhm.71394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.06.2026. Verfasst von Han Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Metal Nanoparticles, Triple Negative Breast Neoplasms. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Hunan Provincial Science & Technology Program.
Abstract (Originalsprache)
Tumor nanocatalytic therapy represents a promising transformative technology for treating malignant tumors, yet is often limited by insufficient catalytic activity and adaptive tumor microenvironment (TME) resistance. Herein, we develop a plasmonic Pt‐CuO 2 nanozyme that integrates plasmonic enhancement with self‐sufficient H 2 O 2 supply for augmented cascade catalytic therapy. The nanozyme comprises Pt nanoparticles (NPs) and CuO 2 nanodots co‐deposited on Au nanostars and encapsulated within PEGylated ZIF‐8 metal–organic frameworks (MOFs). It exhibits strong near‐infrared localized surface plasmon resonance, enables intrinsic H 2 O 2 generation, and depletes glutathione, effectively disrupting intratumoral redox homeostasis. Under acidic TME conditions, the MOFs degrade, releasing Pt NPs and CuO 2 nanodots to produce ∙OH via peroxidase‐like and Fenton‐like catalytic reactions. Plasmonic heating and “hot electron” injection under 808 nm laser irradiation further promote ∙OH generation. This process induces mitochondrial dysfunction, suppresses adenosine triphosphate biosynthesis and downregulates heat shock proteins, thereby increasing thermal sensitivity of cancer cells and enhancing the efficacy of mild plasmonic hyperthermia therapy (PHT). In a triple‐negative breast cancer murine model, the nanozyme demonstrates superior anticancer performance through the synergy of plasmon‐enhanced catalysis, self‐supplied H 2 O 2 , redox homeostasis disruption, and mild PHT. This study provides a novel strategy for efficient nanocatalytic therapy with substantial potential for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, Central South University, Changsha, Hunan, China.
- Furong Laboratory, Changsha, Hunan, China.
ORCID-Profile: Ming Li
Förderung
- National Natural Science Foundation of China
- Hunan Provincial Science & Technology Program
Zitieren
APA
Wang, H., Chen, M., Chen, H., Li, J., & Li, M. (2026). Plasmonically Reinforced Self‐Sufficient Nanozymes Dysregulating Redox Homeostasis for Augmented Cascade Catalytic Oncotherapy. Advanced Healthcare Materials, 15(29). https://doi.org/10.1002/adhm.71394
Vancouver
Wang H, Chen M, Chen H, Li J, Li M. Plasmonically Reinforced Self‐Sufficient Nanozymes Dysregulating Redox Homeostasis for Augmented Cascade Catalytic Oncotherapy. Advanced Healthcare Materials. 2026;15(29). doi:10.1002/adhm.71394
BibTeX
@article{Wang2026,
author = {Wang, Han and Chen, Mingyang and Chen, Haiyan and Li, Jinghang and Li, Ming},
title = {Plasmonically Reinforced Self‐Sufficient Nanozymes Dysregulating Redox Homeostasis for Augmented Cascade Catalytic Oncotherapy},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {29},
doi = {10.1002/adhm.71394}
}
EUVIMED